The safety and efficacy of eptifibatide-facilitated percutaneous coronary angioplasty versus primary percutaneous coronary angioplasty alone

Trial Profile

The safety and efficacy of eptifibatide-facilitated percutaneous coronary angioplasty versus primary percutaneous coronary angioplasty alone

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2014

At a glance

  • Drugs Eptifibatide (Primary) ; Heparin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms ASSIST
  • Most Recent Events

    • 01 Aug 2009 Results published in Circulation: Cardiovascular Interventions.
    • 28 Oct 2008 Status changed from recruiting to completed.
    • 15 Oct 2008 Results presented at the 2008 Transcatheter Cardiovascular Therapeutics Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top